SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Massimo Ubaldi, Antonio Giordano, Ilenia Severi, Hongwu Li, Marsida Kallupi, Giordano de Guglielmo, Barbara Ruggeri, Serena Stopponi, Roberto Ciccocioppo, Nazzareno Cannella, Activation of Hypocretin-1/Orexin-A Neurons Projecting to the Bed Nucleus of the Stria Terminalis and Paraventricular Nucleus Is Critical for Reinstatement of Alcohol Seeking by Neuropeptide S, Biological Psychiatry, 2015,

    CrossRef

  2. 2
    Manuel Alcaraz-Iborra, Inmaculada Cubero, Do Orexins contribute to impulsivity-driven binge consumption of rewarding stimulus and transition to drug/food dependence?, Pharmacology Biochemistry and Behavior, 2015, 134, 31

    CrossRef

  3. 3
    Zachary D. Brodnik, David L. Bernstein, Courtney D. Prince, Rodrigo A. España, Hypocretin receptor 1 blockade preferentially reduces high effort responding for cocaine without promoting sleep, Behavioural Brain Research, 2015, 291, 377

    CrossRef

  4. 4
    Courtney D. Prince, Andrew R. Rau, Jordan T. Yorgason, Rodrigo A. España, Hypocretin/Orexin Regulation of Dopamine Signaling and Cocaine Self-Administration Is Mediated Predominantly by Hypocretin Receptor 1, ACS Chemical Neuroscience, 2015, 6, 1, 138

    CrossRef

  5. 5
    L.E. Mueller, M.A. Kausch, T. Markovic, D.A.A. MacLaren, D.M. Dietz, J. Park, S.D. Clark, Intra-ventral tegmental area microinjections of urotensin II modulate the effects of cocaine, Behavioural Brain Research, 2015, 278, 271

    CrossRef

  6. 6
    Brandon S. Bentzley, Gary Aston-Jones, Orexin-1 receptor signaling increases motivation for cocaine-associated cues, European Journal of Neuroscience, 2015, 41, 9
  7. You have free access to this content7
    Corey Baimel, Selena E Bartlett, Lih-Chu Chiou, Andrew J Lawrence, John W Muschamp, Omkar Patkar, Li-Wei Tung, Stephanie L Borgland, Orexin/hypocretin role in reward: implications for opioid and other addictions, British Journal of Pharmacology, 2015, 172, 2
  8. 8
    Quanhui Chen, Luis Lecea, Zhian Hu, Dong Gao, The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry, Medicinal Research Reviews, 2015, 35, 1
  9. 9
    David A. Perrey, Ann M. Decker, Jun-Xu Li, Brian P. Gilmour, Brian F. Thomas, Danni L. Harris, Scott P. Runyon, Yanan Zhang, The importance of the 6- and 7-positions of tetrahydroisoquinolines as selective antagonists for the orexin 1 receptor, Bioorganic & Medicinal Chemistry, 2015,

    CrossRef

  10. 10
    Hans G. Cruz, Petra Hoever, Bijan Chakraborty, Kerri Schoedel, Edward M. Sellers, Jasper Dingemanse, Assessment of the Abuse Liability of a Dual Orexin Receptor Antagonist: A Crossover Study of Almorexant and Zolpidem in Recreational Drug Users, CNS Drugs, 2014, 28, 4, 361

    CrossRef

  11. 11
    Rémi Martin-Fardon, Friedbert Weiss, Blockade of hypocretin receptor-1 preferentially prevents cocaine seeking, NeuroReport, 2014, 1

    CrossRef

  12. 12
    J. W. Muschamp, J. A. Hollander, J. L. Thompson, G. Voren, L. C. Hassinger, S. Onvani, T. M. Kamenecka, S. L. Borgland, P. J. Kenny, W. A. Carlezon, Hypocretin (orexin) facilitates reward by attenuating the antireward effects of its cotransmitter dynorphin in ventral tegmental area, Proceedings of the National Academy of Sciences, 2014, 111, 16, E1648

    CrossRef

  13. 13
    Stephen V Mahler, David E Moorman, Rachel J Smith, Morgan H James, Gary Aston-Jones, Motivational activation: a unifying hypothesis of orexin/hypocretin function, Nature Neuroscience, 2014, 17, 10, 1298

    CrossRef

  14. 14
    Shaun Yon-Seng Khoo, Robyn Mary Brown, Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?, CNS Drugs, 2014, 28, 8, 713

    CrossRef

  15. 15
    Davide Quarta, Ilse Smolders, Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission, European Journal of Pharmaceutical Sciences, 2014, 57, 2

    CrossRef

  16. You have free access to this content16
    Christina J Perry, Isabel Zbukvic, Jee Hyun Kim, Andrew J Lawrence, Role of cues and contexts on drug-seeking behaviour, British Journal of Pharmacology, 2014, 171, 20
  17. 17
    Angie M. Cason, Gary Aston-Jones, Role of orexin/hypocretin in conditioned sucrose-seeking in female rats, Neuropharmacology, 2014, 86, 97

    CrossRef

  18. 18
    Jason M. Uslaner, Christopher J. Winrow, Anthony L. Gotter, Anthony J. Roecker, Paul J. Coleman, Pete H. Hutson, Anh D. Le, John J. Renger, Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement, Behavioural Brain Research, 2014, 269, 61

    CrossRef

  19. 19
    Takeshi Sakurai, The role of orexin in motivated behaviours, Nature Reviews Neuroscience, 2014, 15, 11, 719

    CrossRef

  20. 20
    Stephen V. Mahler, David E. Moorman, Matthew W. Feltenstein, Brittney M. Cox, Katelyn B. Ogburn, Michal Bachar, Justin T. McGonigal, Shannon M. Ghee, Ronald E. See, A rodent “self-report” measure of methamphetamine craving? Rat ultrasonic vocalizations during methamphetamine self-administration, extinction, and reinstatement, Behavioural Brain Research, 2013, 236, 78

    CrossRef

  21. 21
    Ainhoa Plaza-Zabala, África Flores, Elena Martín-García, Rocío Saravia, Rafael Maldonado, Fernando Berrendero, A Role for Hypocretin/Orexin Receptor-1 in Cue-Induced Reinstatement of Nicotine-Seeking Behavior, Neuropsychopharmacology, 2013, 38, 9, 1724

    CrossRef

  22. 22
    Ainhoa Plaza-Zabala, Xuan Li, Mike Milovanovic, Jessica A. Loweth, Rafael Maldonado, Fernando Berrendero, Marina E. Wolf, An investigation of interactions between hypocretin/orexin signaling and glutamate receptor surface expression in the rat nucleus accumbens under basal conditions and after cocaine exposure, Neuroscience Letters, 2013, 557, 101

    CrossRef

  23. 23
    Robyn Mary Brown, Andrew John Lawrence, Ascending orexinergic pathways and alcohol-seeking, Current Opinion in Neurobiology, 2013, 23, 4, 467

    CrossRef

  24. 24
    Angie M. Cason, Gary Aston-Jones, Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist, Psychopharmacology, 2013, 228, 3, 499

    CrossRef

  25. 25
    Robyn Mary Brown, Shaun Yon-Seng Khoo, Andrew John Lawrence, Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats, The International Journal of Neuropsychopharmacology, 2013, 16, 09, 2067

    CrossRef

  26. 26
    David C.S. Roberts, Amanda Gabriele, Benjamin A. Zimmer, Conflation of cocaine seeking and cocaine taking responses in IV self-administration experiments in rats: Methodological and interpretational considerations, Neuroscience & Biobehavioral Reviews, 2013, 37, 9, 2026

    CrossRef

  27. 27
    Haoran Zhang, Zhi Lian, Shiyan Yan, Yanping Bao, Zhimin Liu, Different Levels in Orexin Concentrations and Risk Factors Associated with Higher Orexin Levels: Comparison between Detoxified Opiate and Methamphetamine Addicts in 5 Chinese Cities, BioMed Research International, 2013, 2013, 1

    CrossRef

  28. 28
    Stephen V. Mahler, Rachel J. Smith, Gary Aston-Jones, Interactions between VTA orexin and glutamate in cue-induced reinstatement of cocaine seeking in rats, Psychopharmacology, 2013, 226, 4, 687

    CrossRef

  29. 29
    Amanda J. Morgan, Steven B. Harrod, Ryan T. Lacy, Emily M. Stanley, Jim R. Fadel, Intravenous prenatal nicotine exposure increases orexin expression in the lateral hypothalamus and orexin innervation of the ventral tegmental area in adult male rats, Drug and Alcohol Dependence, 2013, 132, 3, 562

    CrossRef

  30. 30
    Tian-Rui Xu, Yang Yang, Richard Ward, Linghuan Gao, Ying Liu, Orexin receptors: Multi-functional therapeutic targets for sleeping disorders, eating disorders, drug addiction, cancers and other physiological disorders, Cellular Signalling, 2013, 25, 12, 2413

    CrossRef

  31. 31
    R. M. Sears, A. E. Fink, M. B. Wigestrand, C. R. Farb, L. de Lecea, J. E. LeDoux, Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus, Proceedings of the National Academy of Sciences, 2013, 110, 50, 20260

    CrossRef

  32. 32
    Esmail Riahi, Fariba Khodagholi, Abbas Haghparast, Role of dorsal hippocampal orexin-1 receptors in associating morphine reward with contextual stimuli, Behavioural Pharmacology, 2013, 24, 4, 237

    CrossRef

  33. 33
    Angie M. Cason, Gary Aston-Jones, Role of orexin/hypocretin in conditioned sucrose-seeking in rats, Psychopharmacology, 2013, 226, 1, 155

    CrossRef

  34. 34
    Brandon S. Bentzley, Kimberly M. Fender, Gary Aston-Jones, The behavioral economics of drug self-administration: A review and new analytical approach for within-session procedures, Psychopharmacology, 2013, 226, 1, 113

    CrossRef

  35. 35
    Mohammad Tabaeizadeh, Rouzbeh Motiei-Langroudi, Hilda Mirbaha, Behnaz Esmaeili, Pouya Tahsili-Fahadan, Mehrak Javadi-Paydar, Majid Ghaffarpour, Ahmad Reza Dehpour, The differential effects of OX1R and OX2R selective antagonists on morphine conditioned place preference in naïve versus morphine-dependent mice, Behavioural Brain Research, 2013, 237, 41

    CrossRef

  36. 36
    Michel Alexander Steiner, Hugues Lecourt, François Jenck, The dual orexin receptor antagonist almorexant, alone and in combination with morphine, cocaine and amphetamine, on conditioned place preference and locomotor sensitization in the rat, The International Journal of Neuropsychopharmacology, 2013, 16, 02, 417

    CrossRef

  37. 37
    Giovana Camila Macedo, Suzi Emiko Kawakami, Thiago Vignoli, Rita Sinigaglia-Coimbra, Deborah Suchecki, The influence of orexins on ethanol-induced behavioral sensitization in male mice, Neuroscience Letters, 2013, 551, 84

    CrossRef

  38. 38
    Nathan A. Holtz, Natalie E. Zlebnik, Marilyn E. Carroll, Differential orexin/hypocretin expression in addiction-prone and -resistant rats selectively bred for high (HiS) and low (LoS) saccharin intake, Neuroscience Letters, 2012, 522, 1, 12

    CrossRef

  39. 39
    Chad Ruoff, Christian Guilleminault, Hypocretin receptor antagonists for insomnia: rationale and clinical data, Clinical Investigation, 2012, 2, 6, 623

    CrossRef

  40. 40
    Ainhoa Plaza-Zabala, África Flores, Rafael Maldonado, Fernando Berrendero, Hypocretin/Orexin Signaling in the Hypothalamic Paraventricular Nucleus is Essential for the Expression of Nicotine Withdrawal, Biological Psychiatry, 2012, 71, 3, 214

    CrossRef

  41. 41
    Jennifer A. Parker, Stephen R. Bloom, Hypothalamic neuropeptides and the regulation of appetite, Neuropharmacology, 2012, 63, 1, 18

    CrossRef

  42. 42
    Rachel J. Smith, Gary Aston-Jones, Orexin / hypocretin 1 receptor antagonist reduces heroin self-administration and cue-induced heroin seeking, European Journal of Neuroscience, 2012, 35, 5
  43. 43
    Thorfinn T. Riday, Eric W. Fish, J. Elliott Robinson, Thomas M. Jarrett, Megan M. McGuigan, C.J. Malanga, Orexin-1 receptor antagonism does not reduce the rewarding potency of cocaine in Swiss–Webster mice, Brain Research, 2012, 1431, 53

    CrossRef

  44. 44
    Gregory C. Sartor, Gary Aston-Jones, Regulation of the ventral tegmental area by the bed nucleus of the stria terminalis is required for expression of cocaine preference, European Journal of Neuroscience, 2012, 36, 11
  45. 45
    Luyi Zhou, Rachel J. Smith, Phong H. Do, Gary Aston-Jones, Ronald E. See, Repeated orexin 1 receptor antagonism effects on cocaine seeking in rats, Neuropharmacology, 2012, 63, 7, 1201

    CrossRef

  46. 46
    Ainhoa Plaza-Zabala, Rafael Maldonado, Fernando Berrendero, The Hypocretin/Orexin System: Implications for Drug Reward and Relapse, Molecular Neurobiology, 2012, 45, 3, 424

    CrossRef

  47. 47
    Nathan J. Marchant, E. Zayra Millan, Gavan P. McNally, The hypothalamus and the neurobiology of drug seeking, Cellular and Molecular Life Sciences, 2012, 69, 4, 581

    CrossRef

  48. 48
    Corey Baimel, Stephanie L. Borgland, William Corrigall, Sleep Hormones, 2012,

    CrossRef

  49. 49
    Rodrigo A. España, Sleep Hormones, 2012,

    CrossRef

  50. 50
    Stephen V. Mahler, Rachel J. Smith, David E. Moorman, Gregory C. Sartor, Gary Aston-Jones, Orexin/Hypocretin System, 2012,

    CrossRef

  51. 51
    Erik B. Oleson, Jasmine M. Richardson, David C. S. Roberts, A novel IV cocaine self-administration procedure in rats: differential effects of dopamine, serotonin, and GABA drug pre-treatments on cocaine consumption and maximal price paid, Psychopharmacology, 2011, 214, 2, 567

    CrossRef

  52. 52
    Jennifer L. Thompson, Stephanie L. Borgland, A role for hypocretin/orexin in motivation, Behavioural Brain Research, 2011, 217, 2, 446

    CrossRef

  53. 53
    Da-Thao Tran, Pascal Bonaventure, Michael Hack, Taraneh Mirzadegan, Curt Dvorak, Michael Letavic, Nicholas Carruthers, Timothy Lovenberg, Steven W. Sutton, Chimeric, mutant orexin receptors show key interactions between orexin receptors, peptides and antagonists, European Journal of Pharmacology, 2011, 667, 1-3, 120

    CrossRef

  54. 54
    Elisabet Jerlhag, Emil Egecioglu, Suzanne L. Dickson, Jörgen A. Engel, Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system, Addiction Biology, 2011, 16, 1
  55. 55
    Rodrigo A. España, James R. Melchior, David C. S. Roberts, Sara R. Jones, Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration, Psychopharmacology, 2011, 214, 2, 415

    CrossRef

  56. 56
    Toshimichi Hata, Jihuan Chen, Kosuke Ebihara, Yukari Date, Yasushi Ishida, Daiichiro Nakahara, Intra-ventral tegmental area or intracerebroventricular orexin-A increases the intra-cranial self-stimulation threshold via activation of the corticotropin-releasing factor system in rats, European Journal of Neuroscience, 2011, 34, 5
  57. 57
    Charlene M. Voorhees, Christopher L. Cunningham, Involvement of the orexin/hypocretin system in ethanol conditioned place preference, Psychopharmacology, 2011, 214, 4, 805

    CrossRef

  58. 58
    Andrea R. Di Sebastiano, Hilary E. Wilson-Pérez, Michael N. Lehman, Lique M. Coolen, Lesions of orexin neurons block conditioned place preference for sexual behavior in male rats, Hormones and Behavior, 2011, 59, 1, 1

    CrossRef

  59. 59
    Luyi Zhou, Wei-Lun Sun, Ronald See, Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction, Pharmaceuticals, 2011, 4, 12, 804

    CrossRef

  60. 60
    Morgan H. James, Janine L. Charnley, Emily M. Levi, Emma Jones, Jiann Wei Yeoh, Doug W. Smith, Christopher V. Dayas, Orexin-1 receptor signalling within the ventral tegmental area, but not the paraventricular thalamus, is critical to regulating cue-induced reinstatement of cocaine-seeking, The International Journal of Neuropsychopharmacology, 2011, 14, 05, 684

    CrossRef

  61. 61
    James R. Shoblock, Natalie Welty, Leah Aluisio, Ian Fraser, S. Timothy Motley, Kirsten Morton, James Palmer, Pascal Bonaventure, Nicholas I. Carruthers, Timothy W. Lovenberg, Jamin Boggs, Ruggero Galici, Selective blockade of the orexin-2 receptor attenuates ethanol self-administration, place preference, and reinstatement, Psychopharmacology, 2011, 215, 1, 191

    CrossRef

  62. 62
    Paul J. Kenny, Tobacco dependence, the insular cortex and the hypocretin connection, Pharmacology Biochemistry and Behavior, 2011, 97, 4, 700

    CrossRef

  63. 63
    Rachel J. Smith, Gary Aston-Jones, α2 Adrenergic and Imidazoline Receptor Agonists Prevent Cue-Induced Cocaine Seeking, Biological Psychiatry, 2011, 70, 8, 712

    CrossRef

  64. 64
    Stephanie L. Borgland, Mark A. Ungless, Antonello Bonci, Convergent actions of orexin/hypocretin and CRF on dopamine neurons: Emerging players in addiction, Brain Research, 2010, 1314, 139

    CrossRef

  65. 65
    Gary Aston-Jones, Rachel J. Smith, Gregory C. Sartor, David E. Moorman, Lema Massi, Pouya Tahsili-Fahadan, Kimberlei A. Richardson, Lateral hypothalamic orexin/hypocretin neurons: A role in reward-seeking and addiction, Brain Research, 2010, 1314, 74

    CrossRef

  66. 66
    M. Kallupi, N. Cannella, D. Economidou, M. Ubaldi, B. Ruggeri, F. Weiss, M. Massi, J. Marugan, M. Heilig, P. Bonnavion, L. de Lecea, R. Ciccocioppo, Neuropeptide S facilitates cue-induced relapse to cocaine seeking through activation of the hypothalamic hypocretin system, Proceedings of the National Academy of Sciences, 2010, 107, 45, 19567

    CrossRef

  67. 67
    Mark G. LeSage, Jennifer L. Perry, Catherine M. Kotz, David Shelley, William A. Corrigall, Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA, Psychopharmacology, 2010, 209, 2, 203

    CrossRef

  68. 68
    Andrea R. Di Sebastiano, Sabrina Yong-Yow, Lauren Wagner, Michael N. Lehman, Lique M. Coolen, Orexin mediates initiation of sexual behavior in sexually naive male rats, but is not critical for sexual performance, Hormones and Behavior, 2010, 58, 3, 397

    CrossRef

  69. 69
    Angie M. Cason, Rachel J. Smith, Pouya Tahsili-Fahadan, David E. Moorman, Gregory C. Sartor, Gary Aston-Jones, Role of orexin/hypocretin in reward-seeking and addiction: Implications for obesity, Physiology & Behavior, 2010, 100, 5, 419

    CrossRef

  70. 70
    Rodrigo A. España, Erik B. Oleson, Jason L. Locke, Bethany R. Brookshire, David C. S. Roberts, Sara R. Jones, The hypocretin–orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system, European Journal of Neuroscience, 2010, 31, 2
  71. 71
    Benjamin Boutrel, Nazzareno Cannella, Luis de Lecea, The role of hypocretin in driving arousal and goal-oriented behaviors, Brain Research, 2010, 1314, 103

    CrossRef